A study published in the journal Science Advances reveals that 9-month-old babies are sensitive to non-adjacent grammatical regularities contained in language components
Speech rhythm and pitch are fundamental in babies’ language acquisition Read More »
Now a work co-led by the Bellvitge Biomedical Research Institute (IDIBELL) and the University of Barcelona (UB) together with the LMU in Munich has studied the antitumor effect of an enzyme elimination in viruses of the poxvirus family
A group from IDIBELL, the Catalan Institute of Oncology and CIBERONC has identified new genes predisposing to different types of polyposis which, if confirmed, could determine the clinical management of carriers.
Researchers identify new genes predisposing to colorectal polyposis Read More »
The Agency for the Management of University and Research Grants (AGAUR) has published this week the final resolution of the call for grants to support the activities of research groups from universities, centers and foundations. In this year’s call, 32 IDIBELL groups have been recognized as Consolidated or Emerging Research Groups, of which 19 will receive funding.
The Generalitat recognizes 32 IDIBELL groups as Consolidated or Emerging Research Groups Read More »
The research group on Cognition and Brain Plasticity from IDIBELL and the UB answered this question with an experiment in the Milan auditorium, with the Milan orchestra and 1,000 members of the public as study participants.
Curiosity or pleasure, what comes first when we listen to a song? Read More »
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL), the Sant Joan de Déu Research Institute (IRSJD), Sant Pau Research Institute (IIB Sant Pau) and the UB generated the first model of this disease that reproduce patients’ characteristics and response to treatment.
DEGS1 also appears as a main actor of mitochondrial function, which may have implications for the management of diseases caused by lipid imbalance.
This is a proposal coordinated by IDIBELL and financed by AGAUR in which 13 other institutions participate. XarSMART will offer projects access to experts in regulatory, eHealth, data science and precision medicine.
Bioinformaticians from the Bellvitge Biomedical Research Institute (IDIBELL) and geneticists from the Molecular Diagnostic Laboratory of the Catalan Institute of Oncology (ICO) joined forces to develop a program that facilitates genetic variants classification, as it collects and combines the available information to offer a first classification of the variants.
A bioinformatics program will accelerate the diagnosis of hereditary cancer Read More »
It is a project that delves into personalized medicine. This trial has been financed by the Carlos III Health Institute through R&D projects call in 2019, and by a grant from the Spanish Society of Cardiology.
